1. Alleviation of AF related symptoms following acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm with flecainide acetate oral inhalation solution. (3rd October 2022) Authors: Camm, A J; Crijns, H J G M; Elvan, A; Tuininga, Y; Badings, E; Kuijper, A F M; De Jong, J S S G; Lee, M; Schellings, D; Van Gelder, I C; Ruskin, J; Kowey, P; Dufton, C; Maupas, J; Belardinelli, L Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Predictors of successful cardioversion of recent-onset atrial fibrillation to sinus rhythm with orally inhaled flecainide. (3rd October 2022) Authors: Ruskin, J; Dufton, C; Maupas, J; Crijns, H; Elvan, A; De Jong, J; Oosterhof, T; Tuininga, Y; Badings, E; Aksoy, I; Nuyens, D; Van Dijk, V; Camm, A J; Kowey, P; Belardinelli, L Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗